Skip to main content
Livermore
Livermore
ZHEN

Dianthus Therapeutics, Inc.

DNTH
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0001690585

In the last 90 days, Dianthus Therapeutics, Inc. insiders filed 0 open-market purchases and 8 sales; 269 institutions reported holding it in 13F filings for Q2 2026, worth $6.40B in total; no superinvestor holds it.

Q2 2024 vs. Q1 2024

How the institutions holding Dianthus Therapeutics, Inc. changed between Q1 2024 and Q2 2024.

All holders in Q2 2024All holders in Q1 2024

13F holders of DNTH: Q1 2024 compared with Q2 2024
MeasureQ1 2024Q2 2024Change
Holders7674−2
Shares26.1M29.7M+3.63M (+13.9%)
Value$782.3M$768.8M−$13.5M (−1.7%)

New holders (28)

Institutions that held Dianthus Therapeutics, Inc. at the end of Q2 2024 but not at the end of Q1 2024.

Institutions new to DNTH in Q2 2024
InstitutionSharesValue% of portfolio
Braidwell LP366,851$9.49M0.30%
Woodline Partners LP250,333$6.48M0.06%
Nuveen Asset Management, LLC86,771$2.25M0.00%
Charles Schwab Investment Management Inc68,567$1.77M0.00%
Rhumbline Advisers32,138$831.7K0.00%
Alliancebernstein L.P.25,010$647.3K0.00%
Alpine Global Management, LLC23,389$605.3K0.11%
Alps Advisors Inc22,915$593.0K0.00%
Swiss National Bank17,300$447.7K0.00%
Point72 (DIFC) Ltd12,900$333.9K0.03%
Corebridge Financial, Inc.12,859$332.9K0.00%
Invesco Ltd.11,135$288.2K0.00%
Winton Group Ltd10,238$265.0K0.02%
UBS Asset Management Americas Inc10,152$262.7K0.00%
California State Teachers Retirement System9,711$251.3K0.00%
New York State Common Retirement Fund9,700$251.0K0.00%
Deutsche Bank AG9,469$245.1K0.00%
Manufacturers Life Insurance Company, The9,102$235.6K0.00%
Voya Investment Management LLC8,116$210.0K0.00%
Legal & General Group Plc8,054$207.3K0.00%
MetLife Investment Management6,085$157.5K0.00%
SG Americas Securities, LLC4,333$112.0K0.00%
Virtus ETF Advisers LLC3,358$86.9K0.04%
Ameritas Investment Partners, Inc.2,342$60.6K0.00%
Amalgamated Bank827$21.0K0.00%
Quarry LP33$8540.00%
Rothschild Investment LLC5$1290.00%
Quest Partners LLC1$260.00%

Sold out (30)

Institutions that held Dianthus Therapeutics, Inc. at the end of Q1 2024 and filed for Q2 2024 without it.

Institutions that sold out of DNTH in Q2 2024
InstitutionShares, Q1 2024Value, Q1 2024
Millennium Management LLC277,213$8.32M
Ally Bridge Group (NY) LLC216,968$6.51M
Susquehanna International Group, LLP205,487$6.16M
Walleye Capital LLC190,266$5.71M
Soleus Capital Management, L.P.100,000$3.00M
Jane Street Group, LLC82,051$2.46M
Hudson Bay Capital Management LP80,000$2.40M
StemPoint Capital LP43,456$1.30M
HRT Financial LP34,174$1.02M
Laurion Capital Management LP25,536$766.1K
Citadel Advisors LLC24,829$744.9K
Hussman Strategic Advisors, Inc.21,000$630.0K
ExodusPoint Capital Management, LP16,996$510.0K
Marathon Trading Investment Management LLC14,500$435.0K
Jump Financial, LLC13,942$418.3K
Squarepoint Ops LLC13,642$409.3K
Balyasny Asset Management LLC13,371$401.1K
Virtu Financial LLC12,995$390.0K
Brevan Howard Capital Management LP12,253$367.6K
Y-Intercept (Hong Kong) Ltd12,090$362.7K
Engineers Gate Manager LP7,786$233.6K
Jefferies Financial Group Inc.7,600$228.0K
LMR Partners LLP7,478$224.3K
XTX Topco Ltd7,219$216.6K
Polymer Capital Management (HK) LTD6,686$200.6K
Acadian Asset Management LLC4,012$120.0K
Tower Research Capital LLC (TRC)3,897$116.9K
EntryPoint Capital, LLC363$10.9K
Fernwood Investment Management, LLC102$3.06K
Macquarie Group Ltd1,824$55